very long--but can't say I'm not disappointed--thought after approval of Afrezza and the partnership announcement the pps would be a lot higher than it is right now---there now won't likely be any substantial movement until well into 2015 when we see how Afrezza is received by the diabetic community
Inovio's proprietary SynCon® design approach, Inovio researchers developed a polyvalent DNA vaccine consisting of three consensus plasmids to broadly target variant virus strains within three distinct families of Ebola and Marburg viruses. In the first part of this study, following two vaccinations using Inovio's proprietary CELLECTRA® electroporation device, 100% of vaccinated guinea pigs were protected from death following a virus challenge
What LIE?? This board is so full of idiots its ridiculous--you being #1 PAL
Inovio's SynCon® DNA vaccine against Ebola and Marburg filoviruses showed 100% protection in early studies in 2013---will the US government help finance this study to Phase III and will the FDA fast track its approval if it continues to be successful further on in the trials??
You couldn't more wrong--looks like AMBS a very nice little announcement today--disproving your nonsense--a lot of paid bashers on this board obviously
I will report this peabrain---you don't need to have a test for dementia---in your case its already well advanced!!!
this drop in price has nothing to do with the company--the whole market took a "dive" as it simply has been "overheated" for some time and was long overdue for a correction---none of the fundamentals of AMBS have changed nor any of the upcoming catalyts----I look upon this situation as a chance to buy more
I agree--nothing has changed--all the catalysts are still there-LymphPro will soon be licensed for early detection of Alzheimer's etc etc. This dip in price is a marvellous buying opportunity!!
Maybe Dr. Kim himself---greatly admire him not only for how he is running this company but also for backing his belief in the science by putting his own money into buying company stock-he's admitted that 99% of his net worth is in INO stock
Sure I'm disappointed in the performance since Mr. Perrin took over--but this situation reminds me of April 2013 when all the "naysayers" were saying the FDA would never allow this trial to even start--I simply refuse to give up on this company---I challenge anyone to show me a biotech company that has the scientific advisory board that In Vivo has---I don't see any of them "abandoning ship"--and I'm sure if they didn't believe this would be successful they would have bailed out long ago-I will continue to "hold tight" as I believe this trial is ultimately going to be the start of a revolutionary treatment for patients who have had little or no hope before
The only thing "Sad" PAL is you--you continually ridicule this company from every conceivable angle and seem to take great pleasure doing so--you define the word narcisist to a tee-vent your stupid opinions somewhere else-
Sure I can--but I don't acknowledge useless "trolls" like you--and that's all you are--all you do all day is respond to any positive messages and ridicule the person doing it--as a result you don't deserve any response--and I won't lower myself to your level to do so
In Vivo has no control over when this trial starts--its up to each of the designated trauma centres/neurosurgeons in charge to decide if the trial entry criteria are met--I rather they take their time getting this started and get everything right
where did you come up with 25-40% number from???
1 40/40 African Green Monkey were up and moving after implantation of the scaffold
2 these monkeys have 98-99% of the genetic profile of humans
3 the "neuroplastisity" reponse in humans is far greater than in this species of monkey (as quoted by Dr. Slotkin on the NVIV scientific advisory board)
4 this trial only has to achieve "safety"-and since this polymer that composes the scaffold was approved and has been used in many applications already by the FDA--this won't be an issue
-I wouldn't bet against this trial AT ALL
and some of the best neurosurgeons in the US are involved in this--and I'm sure if they thought this was some kind of "crapshoot" they wouldn't even bother participating in it
nobody could care one iota for your stupid comments--you have been bashing this stock from day 1--so why are you back? just to antagonize we who believe in this company and their mission---go share your "expert opinion" on another board--but I'm sure you have been a pain in the #$%$ everywhere you've turned up
The biggest "joke" is you and your "ilk" PAL---take you're "shortie" act somewhere else!!!
I would bet if this is very successful on patients who meet the criteria for inclusion in this trial-then neurosurgeons will "throw caution to the wind" and start using it in patients who don't fit the typical criteria--because patients and their families will be clamoring for it-and who could blame them if the alternative is long term (if not permanent) disability